Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combinations of PBD-based antibody drug conjugates with Bcl-2 inhibitors

Combinations of PBD-based antibody drug conjugates with Bcl-2 inhibitors

US Patent 11027021 · Granted Jun 8, 2021

Estimated economic value: $140,333,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cysteine mutated antibodies for conjugation2024
Glypican 3 antibodies and conjugates thereof2023
Glypican 3 antibodies and conjugates thereof2023
Exercise chair2023
Humanized antibodies to LIV-1 and use of same to treat cancer2022
Combinations of PBD-based antibody drug conjugates with FLT3 inhibitors2021
Combinations of PBD-based antibody drug conjugates with FLT3 inhibitors2021
Combinations of PBD-based antibody drug conjugates with FLT3 inhibitors2021
Combinations of PBD-based antibody drug conjugates with FLT3 inhibitors2021
Humanized antibodies to LIV-1 and use of same to treat cancer2017
Humanized antibodies to LIV-1 and use of same to treat cancer2016
Water soluble binder compositions containing beta-hydroxy urethanes and polyfunc1994